Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Each is an incretin-mimetic peptide backed by its own substantial clinical dataset but the fixed-ratio pairing is a formulation convenience for research only, has never been evaluated as a combination product in a dedicated clinical trial, and should not be assumed to have any pharmacology beyond the additive behavior of its two well-characterized components
Deficiencies in thyroid, gonadal, adrenal or growth hormone axes are addressed according to the pattern
TB-500 + BPC-157 Stack (5 mg Vials) Dosage Protocol TB-500 Dosage Chart TB-500 is dosed at 1.25 mg weekly via subcutaneous injection in educational protocols
The Therapeutic Goods Administration (TGA) has already approved a higher dose of semaglutide, the active ingredient in Ozempic, to be sold as Wegovy in Australia for weight loss among those with a body mass index (BMI) over 30 but this is not yet available due to supply shortages
